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versus perfluoropropane (C3F8) tamponade 
and short term face-down position for macular 
hole repair: a randomized prospective study
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Abstract 
Background: To compare early visual and anatomical outcomes after either sulfur hexafluoride (SF6) or perfluoropro-
pane (C3F8) tamponade for macular hole repair.
Methods: 147 eyes affected by primary full-thickness macular hole underwent pars plana vitrectomy with dye 
assisted removal of the internal limiting membrane and gas tamponade. Prone position was prescribed for 48 h after 
surgery. All patients were divided into 3 groups depending on the size of the hole: small (<250 µm), medium (>250–
<400 µm) or large (>400 µm). Eyes within the same group randomly received either SF6 (70 eyes) or C3F8 (77 eyes). A 
complete ophthalmic evaluation, including best corrected visual acuity and anatomic status of the macular holes, was 
conducted preoperatively, at 1 week and 1 month after surgery. Macular hole volume was calculated using optical 
coherence tomography scans. The Wilcoxon Signed Ranks Test, the Mann–Whitney Test, the Spearman’s rank-order 
correlation coefficient and the study of variance for repeated measures were used for statistical analysis.
Results: Mean best-corrected visual acuity improved from 0.92 logMAR to 0.28 logMAR (P < 0.001). A reduction of 
the dimensions of macular holes was observed in all cases, with a total repair of 90 % (63/70 eyes) in the SF6 group 
and 91 % in the C3F8 group (70/77 eyes). There was a negative correlation between the initial minor diameter, the 
volume of the hole and the rate of anatomic success.
Conclusions: Short-term anatomical and visual outcomes were similar in eyes treated with either SF6 or C3F8, inde-
pendently of the stage of the macular hole. The initial volume and the minor diameter of the hole may be considered 
as valid tools for predicting surgical success. Age and gender did not appear to have influenced the prognosis.
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© 2016 Casini et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
A macular hole (MH) is a full thickness defect of the 
retinal neuroepithelium involving the fovea [1]. It is idi-
opathic in most cases and is the result of a centrifuge 
movement of photoreceptors, under the effect of vitreo-
macular forces [2]. Idiopathic macular hole (IMH) has 
an incidence rate from 7.8 to 30 cases every 100,000 cit-
izens [3] and it is three times more frequent in women 
[4]. IMH usually affects only one eye, but it can be found 
in both eyes in 11.7 % of the cases. The risk for a patient 
with macular hole in one eye, to develop it in the fellow 
one, ranges from 2 to 15  %, depending on the presence 
of vitreous detachment [5]. Female gender and age over 
65 years are present in 67–72 % of the cases [6].
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The most widely accepted hypothesis concerning idi-
opathic macular hole pathogenesis is an abnormal anter-
oposterior vitreous traction [7]. There is an adhesive 
interaction between the posterior vitreous cortex and 
the internal limiting membrane (ILM). When age-related 
physiologic posterior vitreous detachment occurs, vitre-
ous cortex remnants persist on the retina surface in 44 % 
of eyes and may form a layer [8]. An anomalous foveal vit-
reoretinal adherence with perifoveal vitreous detachment 
may be associated to vitreomacular traction, leading to 
distortion of the foveal surface and hole formation. Fur-
thermore, fibrocellular proliferation on the top of the inner 
retinal surface is supposed to support the formation of 
macular holes. Fibrocellular proliferation is also suspected 
to be responsible for the reopening of the macular hole 
or the persistence of the hole in spite of surgery [9]. Gass 
and Johnson [10, 11] described a classification scheme for 
idiopathic macular holes and their prodromal injuries. In 
1995, Gass [7] proposed a microscopic classification of 
stages of development of a macular hole. More recently the 
International Vitreomacular Traction Study (IVTS) Group 
developed an optical coherence tomography (OCT)-based 
anatomic classification system for diseases of the vitreo-
macular interface [12]. It has been clinically established 
that impending macular holes have a 50 % chance to evolve 
to a spontaneous closure with the resolution of symptoms 
[6]. They are therefore observed and not surgically treated. 
However, a spontaneous resolution, with hole closure and 
a restoration of the normal foveal contour, is very rare in 
full-thickness macular holes. It occurs in 2–4 % of the eyes 
[13, 14] therefore these cases are usually treated surgically 
by pars plana vitrectomy, with or without peeling of the 
internal limiting membrane.
Kelly and Wendel pioneered macular hole surgery 
in 1991 when they proposed vitrectomy by pars plana 
(PPV) with gas tamponade [15]. Internal limiting mem-
brane peeling can be associated to vitrectomy in order to 
remove any tractional component.
Peeling of ILM has a success ranging from 92 to 97 % 
whereas PPV without peeling has success ranging from 
78 to 89 % [16–20]. Biomaterials are used to replace the 
vitreous offering the advantage to stably buffer the retina, 
reduce intraocular streams, sustain globe volume and 
favour the flattening of the retinal profile. In macular hole 
surgery, gas tamponade represents the first choice among 
biomaterials, including sterile air, perfluoropropane and 
sulfur hexafluoride, which are the most frequently used.
Methods
Between November 2014 and July 2015, 147 eyes of 141 
patients affected by small (<250  µm), medium (>250–
<400  µm) or large (>400  µm) idiopathic full-thickness 
macular holes were assessed for this study at the Depart-
ment of Ophthalmology, Pisa University, Italy. We 
received approval by the Ethical Review Board of the 
University of Pisa. The study was performed in adherence 
to the tenets of the Declaration of Helsinki; all patients 
signed an informed consent form.
To be eligible, patients had to show a macular hole 
diagnosis confirmed by fundus examination and optical 
coherence tomography (OCT) images.
Preoperatively, at 1 week and 1 month after surgery, all 
the patients underwent a complete ophthalmic exami-
nation, including best corrected visual acuity (BCVA), 
Goldman applanation tonometry, fundus examination 
and optical coherence tomography (OCT) (3D OCT-
2000 Spectral Domain, Topcon, Japan) using Macu-
lar Mode tool of the instrument (3D 6.0  ×  6.0  mm; 
512  ×  128). The surgical treatment included 25 Gauge 
pars plana vitrectomy (PPV), posterior vitreous detach-
ment, peeling of the epiretinal membrane, dye assisted 
peeling of the internal limiting membrane (ILM) using 
brilliant blue G (Brilliant Peel®, Fluoron GmbH, Ulm, 
Germany) and an injection of gas tamponade. The 
stained ILM was peeled using an end gripping for-
ceps (Grieshaber Asymmetrical Forceps, DSP, Alcon, 
Fort Worth, Texas, USA). Gas fluid exchange was per-
formed with either 20  % sulfur hexafluoride (SF6, ALA 
SF6—111201, Alamedics GMBH & CO. KG) or 14  % 
perfluoropropane (C3F8, ALA C3F8—111401, Alamedics 
GMBH & CO. KG). All patients laid in prone position 
for 48  h after surgery. Phakic patients also underwent 
cataract surgery in the same time as the vitrectomy. 
Patients with secondary macular holes, previous retinal 
detachment and recurrence holes were excluded from 
the study.
We divided all the patients into three groups: 
small (<250  µm), medium (>250–<400  µm) and large 
(>400 µm) macular holes according to the International 
Vitreomacular Traction Study Group Classification [12]. 
The size of the macular hole was defined as the minimum 
hole width drawing a line with the caliper parallel to the 
retinal pigment epithelium. Patients within the same 
group were randomly treated either with SF6 or C3F8.
OCT scans let us calculate the volume (V) of the mac-
ula hole using the minor diameter (d), the major diameter 
(D) and the height (H) of the hole. The shape of the hole 
approximately resembles a truncated cone (Fig. 1): in this 
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Statistical analysis was performed using counts and 
percentages for qualitative variables (gender or type of 
tamponade) and ordinal variables (stage); media and 
standard deviation for quantitative Gaussian variables 
(age); medians and interquartile ranges for non-Gaussian 
quantitative variables (volume of macular hole). A con-
tingency table was used to display the frequency distribu-
tion of type of the gas used and stage of the macular hole. 
Spearman’s test was used to analyse correlation between 
the two variables. The trend of visual acuity over time 
was graphically displayed using lines charts. We used 
Wilcoxon Signed Ranks Test to analyse modification 
of visual acuity and hole volume over time. The rate of 
improvement at each time point was compared in each 
group using the Mann–Whitney Test. The Spearman’s 
rank-order correlation coefficient test was used to ana-
lyse correlation between initial major diameter, minor 
diameter and volume of the macular hole and rate of 
anatomic success. Inferential analysis was made with the 
study of variance for repeated measures. We also evalu-
ated some possible bias such as age and gender. Statistical 
analysis was completed using software SPSS (Ver 21.0) 
for windows. Differences were considered significant 
when P < 0.05.
Results
147 eyes of 141 patients, with a mean age of 72 ± 9 years, 
were included in the study. 70 of them underwent PPV 
and SF6 tamponade; 77 patients PPV and C3F8 tampon-
ade. According to IVTS classification [12], 47 patients 
presented a macular hole classified as small, 51 as 
medium and 49 as large. We divided all the patients into 
three groups, depending on the stage of the macular hole. 
Patients within the same group were randomly treated 
either with SF6 or C3F8. The distribution of cases depend-
ing on stage and gas tamponade is shown in Table 1.
There was a statistically significant increase in BCVA 
after surgery in all the three groups with a mean BCVA 
improvement from 0.92 logMAR to 0.28 logMAR at the 
last follow up (P  <  0.01). Pre and post-operative BCVA 
measurements are summarized in Table 2. The trend of 
mean BCVA over time, depending on the stage of the 
macular hole, is represented in Fig. 2.
The rate of improvement at each time point was com-
pared between groups using the Mann–Whitney Test. 
Patients treated with SF6 experienced a greater improve-
ment of their BCVA than those treated with C3F8 at 
1 week postoperatively (61 vs. 39 %) (P < 0.01) indepen-
dently of the stage of the hole. The difference is not sig-
nificant at 1  month follow up (66 vs. 74  %). The OCT 
scans let us calculate major diameter, minor diameter, 
height and volume of the macular holes.
A reduction of the dimensions of macular holes was 
observed in all cases and a total repair was obtained in 
133 of 147 eyes (90  %). Mean macular hole volumes in 
each group, at the different time points are displayed in 
Table 2.
A contingency table (Table  3) shows the number and 
the percentage of complete closure depending on the 
stage of disease and the type of gas used. The percent-
age of anatomic success reduces from small hole group to 
large hole group (Spearman test, P = 0.009).
There was a negative correlation between the initial 
major diameter and the volume of the hole and rate of 
anatomic success (Spearman’s rank-order correlation 
coefficient, rs = −0.7, P < 0.05). No correlation was found 
between the rate of complete anatomic closure and the 
minor diameter of the hole. No post-operative complica-
tions were observed.
Discussion
The efficacy of pars plana vitrectomy (PPV) for the treat-
ment of macular hole has been known since 1991 when 
Kelly and Wendel [15] described a five steps technique 
and reported a success rate of 58 %. Since then, consider-
able strides forward have been made and the PPV for the 
treatment of macular hole has become a safe procedure 
performed worldwide. Recent publications described 
Fig. 1 The shape of the hole approximately resembles a truncated 
cone. To calculate the volume (V) of the macula hole we used the 
minor diameter (d), the major diameter (D) and the height (H) of the 
hole
Table 1 Distribution of cases depending on stage and gas 
tamponade
All the patients were divided into three groups depending on the narrowest 
width of the hole drawing a line with the caliper tool parallel to the retinal 
pigment epithelium: small (<250 µm), medium (>250–<400 µm) and large 
(>400 µm). SF6 = sulfur hexafluoride; C3F8 = perfluoropropane
Type of tamponade Size of the macular hole
Small Medium Large Total
SF6 22 27 21 70
C3F8 25 24 28 77
Total 47 51 49 147
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a rate of anatomic repair that ranges from 80 to 97.1  % 
[21–24]. However, several topics are still debated, among 
which whether or not to peel the internal limiting mem-
brane (ILM), the use and the choice of the dye for bet-
ter IML visualization, whether to prescribe or not the 
face-down position, its duration and the choice of the 
tamponade. Usually gas tamponades are preferred even if 
good results have been reported after heavy silicone oil 
use [25].
Intraocular gases have the capacity for isolating and 
sealing to area of the hole; in addition they effect a 
mechanical tamponade due to the buoyancy of the gas 
and provide a template for glial cells migration, promot-
ing the healing of the hole.
SF6, C3F8 and sterile air are the most used gas tampon-
ade for macular hole surgery.
Which is the tamponade that ensures the best results is 
still a debated topic. Kelly and Wendel in their pioneer-
ing study used SF6, a short acting gas employed in many 
other subsequent studies. Other authors used a long act-
ing gas like C3F8 thinking that a prolonged tamponade 
effect may lead to a larger anatomic success rate [26, 
27]. Comparative studies reported similar closure rates 
in either room air versus SF6 and SF6 versus C3F8 [28–
30]. Also in this study there were no significant differ-
ences regarding the anatomic closure, independently of 
the stage of the macular hole. The repair of the macular 
hole by ganglion and Muller cells starts from the fourth 
day after vitrectomy and finishes about on the seventh 
Table 2 Pre and post-operative values of best corrected visual acuity (BCVA) and macular hole volume (MHV)
We divided the patients into two groups depending on the type of tamponade used. Visual acuity is expressed in LogMAR and hole volume in µm3. SF6 = sulfur 
hexafluoride; C3F8 = perfluoropropane; small (<250 µm), medium (>250–<400 µm), large (>400 µm)
Size of the hole SF6 C3F8
Preoperatively 1 week 1 month preoperatively 1 week 1 month
Small
 BCVA 0.643 0.225 0.175 0.695 0.35 0.085
 MHV 21476439.05 2659017.94 125964 22394832.6 2237618.05 117937.53
Medium
 BCVA 0.7333 0.36 0.316 1 0.7 0.38
 MHV 38628154.71 1855745.73 1535126.93 37941937.36 1946731.8 1694831.07
Large
 BCVA 1.305 0.426 0.413 1.2 0.75 0.35
 MHV 173154648.9 91131802.78 8354755.33 169315684.3 87531967.08 7682391.04
Fig. 2 Trend of mean best corrected visual acuity over time, depending on the size of the macular hole and the tamponade used. SF6 = sulfur 
hexafluoride; C3F8 = perfluoropropane; small (<250 µm), medium (>250–<400 µm) and large (>400 µm)
Table 3 Macular hole closure rate at  1  month postopera-
tively
Number and percentage of complete closure of the macular hole depending on 
stage and type of tamponade




Size of the macular hole
Small Medium Large Total
SF6 21 (95 %) 25 (93 %) 17 (81 %) 63 (90 %)
C3F8 25 (100 %) 22 (92 %) 23 (82 %) 70 (91 %)
Total 46 (98 %) 47 (92 %) 40 (82 %) 133 (90 %)
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day and this was demonstrated using OCT observa-
tions in research completed by Sato [31] and Masuyama 
[32]. Our work focused on short term effects of gas tam-
ponade on macular hole recovery and confirmed that 
the reparation was almost complete at one week after 
surgery. This provides the rationale for the use of short 
acting gases or sterile air. C3F8 provides a prolonged tam-
ponade effect and is usually preferred in case of big size 
holes. All patients enrolled in this study laid in face-down 
position for 48 h after surgery. The value of prone posi-
tion and its duration are still debated. Recent compara-
tive studies reported similar anatomic success rates in 
face-down positioning and non-supine positioning and 
comparing long-term and short-term positioning after 
macular hole surgery [33–37]. Some authors highlight a 
possible role of strict head position in myopic eyes and 
in larger holes [35, 38]. A short period of prone position 
may in the same time promote successful hole closure 
and reduce patient discomfort as well.
In this study multivariate analysis for repeated meas-
ures allowed us to analyse the effect on visual acuity 
depending on the type of tamponade and to determine 
the confounding effect on the volume of the hole. All 
patients experienced a statistically significant improve-
ment of their visual acuity after surgery, but with different 
velocity, depending on the gas tamponade used. Patients 
treated with C3F8 experienced a delay recovery of their 
BCVA, partly due to the longer time for reabsorption of 
the tamponade, but reached similar visual results at the 
last follow up if compared with the ones treated with SF6.
To be able to predict the success of an intervention 
has always been an arduous challenge for every surgeon. 
Regarding macular hole repair, several prognostic fac-
tors have been investigated, among which duration of the 
symptoms, stage and dimension of the hole (less or more 
than 400 microns), preoperative visual acuity. The smaller 
is the size of the hole, the lower is the time between the 
onset of symptoms and the intervention, the better are 
the results, both anatomical and functional. The major 
diameter of 400 microns may be a valid but approximate 
cut off to differentiate the macular hole morphology.
In our opinion macular hole volume calculation may 
be a promising tool to better represent the variable mor-
phology of the holes. To our knowledge no other stud-
ies have considered the hole volume as a prognostic 
tool. Although at present the calculation of the volume 
requires the caliper tool and may be a laborious task, a 
tool for automated calculation could be included in the 
software of the OCT instrument in order to make the 
procedure quicker. In other papers, minimum hole diam-
eter [39], basal hole diameter [40] and hole height [41] 
have been studied as prognostic tools for postoperative 
visual outcomes. We found a correlation between the 
initial minor diameter and the volume of the hole and 
the rate of anatomic closure. However further studies are 
required to confirm these findings.
Conclusion
In conclusion both SF6 and C3F8 are a valid choice for 
macular hole surgical repair. Short acting gas has the 
advantage of involve a faster recovery of visual acu-
ity and a more rapid return to work. This may be useful 
for those who need to travel in airplane. The initial vol-
ume and minor diameter of the hole may be considered 
as valid tools for predicting surgical success in macular 
hole repair. The effects of age and gender do not appear 
to influence the prognosis.
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